top of page

ALOPECIA
CURRENTLY ENROLLING TRIALS

pfizer.png

An Interventional PK, PD, Phase 1, Open-Label Study to Investigate PK and PK of Multiple-Dose Ritlecitinib in Children 6 to less than 12 years of Age with Severe Alopecia Areata

Open for participants between age 6 to < 12 years with a clinical diagnosis of severe alopecia areata without evidence of terminal hair regrowth within the previous 12 months. 

​

Requirements:

  • ≥ 50% scalp hair loss due to AA (SALT score of ≥ 50)

 

Further inclusion/exclusion criteria apply. If you think you may qualify, please take our pre-screen assessment.

UPCOMING CLINICAL TRIALS

Don't qualify for any of our trials?

Note: If you are under the age of 18, please have your parent/guardian call us directly at 847-663-8530.

Thanks for submitting!

We begin new trials often. If you do not qualify for our current studies, please leave your information, and we'll keep you updated of any upcoming trials that may be right for you.

©2023 by Derm CTU. Find us on:

  • Facebook
bottom of page